160 related articles for article (PubMed ID: 20939116)
1. Comparative analysis of dideoxy sequencing, the KRAS StripAssay and pyrosequencing for detection of KRAS mutation.
Gao J; Li YY; Sun PN; Shen L
World J Gastroenterol; 2010 Oct; 16(38):4858-64. PubMed ID: 20939116
[TBL] [Abstract][Full Text] [Related]
2. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
de Macêdo MP; de Melo FM; Lisboa BC; Andrade LD; de Souza Begnami MD; Junior SA; Ribeiro HS; Soares FA; Carraro DM; da Cunha IW
Exp Mol Pathol; 2015 Jun; 98(3):563-7. PubMed ID: 25835782
[TBL] [Abstract][Full Text] [Related]
3. KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice.
Sundström M; Edlund K; Lindell M; Glimelius B; Birgisson H; Micke P; Botling J
BMC Cancer; 2010 Dec; 10():660. PubMed ID: 21122130
[TBL] [Abstract][Full Text] [Related]
4. [The role of KRAS gene mutation testing in colorectal cancer--a predictive biomarker of response to EGFR inhibitors therapy].
Rako I; Jakić-Razumović J; Caban D; Sertić J; Katalinić D; Golem H; Plestina S
Lijec Vjesn; 2011; 133(11-12):403-7. PubMed ID: 22329297
[TBL] [Abstract][Full Text] [Related]
5. The KRAS StripAssay for detection of KRAS mutation in Egyptian patients with colorectal cancer (CRC): a pilot study.
Abd El Kader Y; Emera G; Safwat E; Kassem HA; Kassem NM
J Egypt Natl Canc Inst; 2013 Mar; 25(1):37-41. PubMed ID: 23499205
[TBL] [Abstract][Full Text] [Related]
6. Duplex reverse-hybridization assay for the simultaneous detection of KRAS/BRAF mutations in FFPE-extracted genomic DNA from colorectal cancer specimens.
Buxhofer-Ausch V; Ausch C; Zeillinger R; Oberkanins C; Dandachi N; Reiner-Concin A; Kriegshäuser G
Dis Markers; 2013; 34(3):171-7. PubMed ID: 23324583
[TBL] [Abstract][Full Text] [Related]
7. [KRAS and BRAF gene mutations in correlation with clinicopathologic features of colorectal carcinoma in Chinese].
Zhu XL; Cai X; Zhang L; Yang F; Sheng WQ; Lu YM; Du X; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):584-9. PubMed ID: 23157824
[TBL] [Abstract][Full Text] [Related]
8. The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues.
Okayama N; Nishioka M; Hazama S; Sakai K; Suehiro Y; Maekawa M; Sakamoto J; Iwamoto S; Kato T; Mishima H; Oka M; Hinoda Y
Jpn J Clin Oncol; 2011 Feb; 41(2):165-71. PubMed ID: 20926413
[TBL] [Abstract][Full Text] [Related]
9. KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells.
Lewandowska MA; Jóźwicki W; Żurawski B
Mol Diagn Ther; 2013 Jun; 17(3):193-203. PubMed ID: 23606169
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection.
Ibrahem S; Seth R; O'Sullivan B; Fadhil W; Taniere P; Ilyas M
Int J Exp Pathol; 2010 Dec; 91(6):500-5. PubMed ID: 21199003
[TBL] [Abstract][Full Text] [Related]
11. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
[TBL] [Abstract][Full Text] [Related]
12. SNaPshot and StripAssay as valuable alternatives to direct sequencing for KRAS mutation detection in colon cancer routine diagnostics.
Fariña Sarasqueta A; Moerland E; de Bruyne H; de Graaf H; Vrancken T; van Lijnschoten G; van den Brule AJ
J Mol Diagn; 2011 Mar; 13(2):199-205. PubMed ID: 21354055
[TBL] [Abstract][Full Text] [Related]
13. KRAS and BRAF mutations in 203 esophageal squamous cell carcinomas: pyrosequencing technology and literature review.
Shigaki H; Baba Y; Watanabe M; Miyake K; Murata A; Iwagami S; Ishimoto T; Iwatsuki M; Yoshida N; Baba H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S485-91. PubMed ID: 23274581
[TBL] [Abstract][Full Text] [Related]
14. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology.
Perez K; Walsh R; Brilliant K; Noble L; Yakirevich E; Breese V; Jackson C; Chatterjee D; Pricolo V; Roth L; Shah N; Cataldo T; Safran H; Hixson D; Quesenberry P
Exp Mol Pathol; 2013 Aug; 95(1):74-82. PubMed ID: 23528430
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.
Borràs E; Jurado I; Hernan I; Gamundi MJ; Dias M; Martí I; Mañé B; Arcusa A; Agúndez JA; Blanca M; Carballo M
BMC Cancer; 2011 Sep; 11():406. PubMed ID: 21943394
[TBL] [Abstract][Full Text] [Related]
17. KRAS mutation testing in colorectal cancer: comparison of the results obtained using 3 different methods for the analysis of codons G12 and G13.
Bihl MP; Hoeller S; Andreozzi MC; Foerster A; Rufle A; Tornillo L; Terracciano L
Diagn Mol Pathol; 2012 Mar; 21(1):14-23. PubMed ID: 22306671
[TBL] [Abstract][Full Text] [Related]
18. [Detection of KRAS gene mutation and its clinical significance in colorectal adenocarcinoma].
Xu C; Liu YL; Huang J; He DM; Hou YY; Ji Y; Hou J; Lu SH; Xu JF; Hu Q; Shi Y; Zhao LJ; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):667-70. PubMed ID: 23302307
[TBL] [Abstract][Full Text] [Related]
19. Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.
Ausch C; Buxhofer-Ausch V; Oberkanins C; Holzer B; Minai-Pour M; Jahn S; Dandachi N; Zeillinger R; Kriegshäuser G
J Mol Diagn; 2009 Nov; 11(6):508-13. PubMed ID: 19797612
[TBL] [Abstract][Full Text] [Related]
20. A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas.
Jancik S; Drabek J; Berkovcova J; Xu YZ; Stankova M; Klein J; Kolek V; Skarda J; Tichy T; Grygarkova I; Radzioch D; Hajduch M
J Exp Clin Cancer Res; 2012 Sep; 31(1):79. PubMed ID: 22995035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
